Upgrade to SI Premium - Free Trial

Boston Scientific (BSX) PT Lowered to $64 at Baird

July 14, 2026 6:24 AM
Baird analyst David Rescott lowered the price target on Boston Scientific (NYSE: BSX) to $64.00 (from $70.00) while maintaining a Outperform rating.

Categories

Analyst PT Change